Rapport Therapeutics, Inc. · NASDAQ:RAPP

Ceesay Abraham sold 8,210 Rapport Therapeutics, Inc. shares (Form 4)

Traded Jul 14, 2026 · Filed Jul 15, 2026

On Jul 14, 2026, Ceesay Abraham (Director, Chief Executive Officer) sold 8,210 Rapport Therapeutics, Inc. shares at an average US$40.00 for US$328K under a trading plan, leaving 539,817 shares. Filed Jul 15, 2026 (Form 4).

Sold
8,210 shares
Price
US$40.00 average (US$39.72 to US$40.57)
Value
US$328K
Holding after
539,817 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 14, 2026Common StockSale5,481US$39.72542,546Direct
Jul 14, 2026Common StockSale2,729US$40.57539,817Direct

Source

View original at SEC

Related